Glucotrack, Inc.
GCTK- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001506983
No open-market purchases or sales by Glucotrack, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Glucotrack, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 5 | 9 | +4 |
| Shares | 2.15M | 2.26M | +112.5K (+5.2%) |
| Value | $742.6K | $593.6K | −$149.0K (−20.1%) |
New holders (4)
Institutions that held Glucotrack, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boston Financial Mangement LLC | 52,744 | $13.8K | 0.00% |
| Cable Hill Partners, LLC | 33,117 | $8.69K | 0.00% |
| Citadel Advisors LLC | 32,717 | $8.34K | 0.00% |
| Accurate Wealth Management, LLC | 22,098 | $5.21K | 0.00% |
Sold out (0)
Institutions that held Glucotrack, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.